Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Giusti

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term QuestionsRaffaele Giusti, Marco Filetti, Giampiero Porzio, et al.
Recenti Progressi in Medicina|April 11, 2019
[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]Raffaele Giusti, Lucilla Verna, Giampiero Porzio, et al.
Clinical Drug Investigation|March 17, 2017
Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case ReportRaffaele Giusti, Marco Mazzotta, Daniela Iacono, et al.
Thoracic Cancer|January 15, 2016
Multidisciplinary approach to fetal adenocarcinoma of the lung: A case reportRaffaele Giusti, Daniela Iacono, Paris Ida, et al.
Case Reports in Oncological Medicine|February 24, 2016
Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous AngiosarcomaMarco Mazzotta, Raffaele Giusti, Daniela Iacono, et al.
Journal of Global Oncology|July 9, 2019
Cancer Care After Natural Disaster: Different Countries, Similar ProblemsLucilla Verna, Alessio Cortellini, Raffaele Giusti, et al.
Tumori|June 22, 2019
Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we knowMarco Filetti, Raffaele Giusti, Arianna Di Napoli, et al.
Journal of Palliative Medicine|May 21, 2024
<i>Letter to the Editor:</i> Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief CommunicationClaudia Fiorani, Cyrielle Tchawa, Andrea Cadoni, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 2, 2017
Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"Lucilla Verna, Raffaele Giusti, Agnese Vannini, et al.
Tumori|April 22, 2017
Integration between oncology and palliative care: a plan for the next decade?Raffaele Giusti, Lucilla Verna, Daniela Iacono, et al.
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Letter to the Editor: Olanzapine for Cachexia-Short-Term Benefit, Long-Term QuestionsRaffaele Giusti, Marco Filetti, Giampiero Porzio, et al.
Recenti Progressi in Medicina|April 11, 2019
[Symptom assessment and chemical coping detection: the assessment of the cancer patient's symptoms between consumption, use and abuse.]Raffaele Giusti, Lucilla Verna, Giampiero Porzio, et al.
Clinical Drug Investigation|March 17, 2017
Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case ReportRaffaele Giusti, Marco Mazzotta, Daniela Iacono, et al.
Thoracic Cancer|January 15, 2016
Multidisciplinary approach to fetal adenocarcinoma of the lung: A case reportRaffaele Giusti, Daniela Iacono, Paris Ida, et al.
Case Reports in Oncological Medicine|February 24, 2016
Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous AngiosarcomaMarco Mazzotta, Raffaele Giusti, Daniela Iacono, et al.
Journal of Global Oncology|July 9, 2019
Cancer Care After Natural Disaster: Different Countries, Similar ProblemsLucilla Verna, Alessio Cortellini, Raffaele Giusti, et al.
Tumori|June 22, 2019
Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we knowMarco Filetti, Raffaele Giusti, Arianna Di Napoli, et al.
Journal of Palliative Medicine|May 21, 2024
<i>Letter to the Editor:</i> Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief CommunicationClaudia Fiorani, Cyrielle Tchawa, Andrea Cadoni, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 2, 2017
Re. "Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey"Lucilla Verna, Raffaele Giusti, Agnese Vannini, et al.
Tumori|April 22, 2017
Integration between oncology and palliative care: a plan for the next decade?Raffaele Giusti, Lucilla Verna, Daniela Iacono, et al.
Pageof 14